Infant Formula
-
Else Nutrition Reports First Quarter 2025 Financial Results and Provides Business Update
Else Nutrition (TSX: BABY) reported Q1 2025 results with steady revenue of $2.1 million CAD. Operating expenses decreased by 48%, leading to a gross profit increase to $0.5 million CAD and a gross margin of 25%. The company is focusing on cost reduction by moving powder formula manufacturing to Europe, strengthening retail partnerships, and advancing plant-based infant nutrition through regulatory channels. A conference call to discuss the results is scheduled for today at 10:00 AM Eastern Time.
-
Yudonglai’s Big Move: Pang Donglai Milk Powder Coming Soon – Moms Eagerly Await Development
Pang Dong Lai, a Chinese retailer known for its exceptional customer service and quality control, plans to enter the infant formula market. Founder Yu Donglai announced the initiative on Douyin, aiming to focus on food safety and quality of life. The news has generated significant excitement among Chinese consumers, particularly expectant mothers who expressed hope for a reliable domestic alternative. Pang Dong Lai, with 13 stores and a central kitchen, generated nearly 17 billion yuan in sales in 2024.
